End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.395 USD | -14.13% | -43.57% | -97.38% |
May. 14 | Acorda Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 10 | Liquidation Plan and Disclosure Statement Filed by Acorda Therapeutics, Inc. | CI |
Business Summary
Number of employees: 102
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Therapies
100.0
%
| 104 | 87.6 % | 118 | 100.0 % | +13.28% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 119 | 100.0 % | 118 | 100.0 % | -0.79% |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,242,376 | 1,234,082 ( 99.33 %) | 278 ( 0.0224 %) | 99.33 % |
Company contact information
Acorda Therapeutics, Inc.
2 Blue Hill Plaza 3rd floor
10965, New York
+914 347 4300
http://www.acorda.comSector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-97.38% | 491K | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.96% | 21.96B | |
-7.52% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- ACOR.Q Stock
- Company Acorda Therapeutics, Inc.